The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study
Introduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mo...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.649902/full |
id |
doaj-a2eb33a054004480861798a62a5e1456 |
---|---|
record_format |
Article |
spelling |
doaj-a2eb33a054004480861798a62a5e14562021-07-06T15:18:03ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-07-011310.3389/fnagi.2021.649902649902The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort StudyNatália Eduarda Furlan0Gustavo José Luvizutto1Pedro Tadao Hamamoto Filho2Silméia Garcia Zanati Bazan3Gabriel Pinheiro Modolo4Natalia Cristina Ferreira5Luana Aparecida Miranda6Juli Thomaz de Souza7Fernanda Cristina Winckler8Edison Iglesias de Oliveira Vidal9Carlos Clayton Macedo de Freitas10Luis Cuadrado Martin11Rodrigo Bazan12Faculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilDepartamento de Fisioterapia Aplicada, Universidade Federal do Triângulo Mineiro, Uberaba, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilFaculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, BrazilIntroduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mortality and functional disability) in stroke patients who underwent cerebral reperfusion therapy at hospital discharge and 90 days after ictus.Methods: This was a retrospective (stroke databank analysis) cohort study of participants who had been diagnosed with ischemic stroke and undergone intravenous cerebral reperfusion therapy or mechanical thrombectomy. The variable of interest was patient age, which was categorized into four groups: (1) up to 59 years; (2) 60 to 69 years; (3) 70 to 79 years old; and (4) above 79 years. The primary outcome was mortality at hospital discharge and 90 days after stroke, and the secondary outcome was functional capacity at hospital discharge and 90 days after stroke.Results: A total of 281 patients was included in the study (235 treated by thrombolysis alone, and 46 treated with mechanical thrombectomy). The mean age of the total sample was 67 ± 13.1 years. The oldest patients had the most unfavorable outcomes, except for mortality rate, at hospital discharge (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001) and 90 days after stroke (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001).Conclusion: Cerebral reperfusion was a viable treatment for ischemic stroke in both elderly and very elderly patients, as it did not increase mortality. However, it was observed that older individuals had worse functional outcomes at hospital discharge and 90 days after stroke.https://www.frontiersin.org/articles/10.3389/fnagi.2021.649902/fullstrokecerebral reperfusionrtPAthrombectomyelderly |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Natália Eduarda Furlan Gustavo José Luvizutto Pedro Tadao Hamamoto Filho Silméia Garcia Zanati Bazan Gabriel Pinheiro Modolo Natalia Cristina Ferreira Luana Aparecida Miranda Juli Thomaz de Souza Fernanda Cristina Winckler Edison Iglesias de Oliveira Vidal Carlos Clayton Macedo de Freitas Luis Cuadrado Martin Rodrigo Bazan |
spellingShingle |
Natália Eduarda Furlan Gustavo José Luvizutto Pedro Tadao Hamamoto Filho Silméia Garcia Zanati Bazan Gabriel Pinheiro Modolo Natalia Cristina Ferreira Luana Aparecida Miranda Juli Thomaz de Souza Fernanda Cristina Winckler Edison Iglesias de Oliveira Vidal Carlos Clayton Macedo de Freitas Luis Cuadrado Martin Rodrigo Bazan The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study Frontiers in Aging Neuroscience stroke cerebral reperfusion rtPA thrombectomy elderly |
author_facet |
Natália Eduarda Furlan Gustavo José Luvizutto Pedro Tadao Hamamoto Filho Silméia Garcia Zanati Bazan Gabriel Pinheiro Modolo Natalia Cristina Ferreira Luana Aparecida Miranda Juli Thomaz de Souza Fernanda Cristina Winckler Edison Iglesias de Oliveira Vidal Carlos Clayton Macedo de Freitas Luis Cuadrado Martin Rodrigo Bazan |
author_sort |
Natália Eduarda Furlan |
title |
The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study |
title_short |
The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study |
title_full |
The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study |
title_fullStr |
The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study |
title_full_unstemmed |
The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study |
title_sort |
impact of age on mortality and disability in patients with ischemic stroke who underwent cerebral reperfusion therapy: a brazilian cohort study |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Aging Neuroscience |
issn |
1663-4365 |
publishDate |
2021-07-01 |
description |
Introduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mortality and functional disability) in stroke patients who underwent cerebral reperfusion therapy at hospital discharge and 90 days after ictus.Methods: This was a retrospective (stroke databank analysis) cohort study of participants who had been diagnosed with ischemic stroke and undergone intravenous cerebral reperfusion therapy or mechanical thrombectomy. The variable of interest was patient age, which was categorized into four groups: (1) up to 59 years; (2) 60 to 69 years; (3) 70 to 79 years old; and (4) above 79 years. The primary outcome was mortality at hospital discharge and 90 days after stroke, and the secondary outcome was functional capacity at hospital discharge and 90 days after stroke.Results: A total of 281 patients was included in the study (235 treated by thrombolysis alone, and 46 treated with mechanical thrombectomy). The mean age of the total sample was 67 ± 13.1 years. The oldest patients had the most unfavorable outcomes, except for mortality rate, at hospital discharge (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001) and 90 days after stroke (mRS > 2; OR: 1.028; 95% CI 1.005 to 1.051; p = 0.017; mRS > 3; OR: 1.043, 95% CI 1.018 to 1.069; p = 0.001).Conclusion: Cerebral reperfusion was a viable treatment for ischemic stroke in both elderly and very elderly patients, as it did not increase mortality. However, it was observed that older individuals had worse functional outcomes at hospital discharge and 90 days after stroke. |
topic |
stroke cerebral reperfusion rtPA thrombectomy elderly |
url |
https://www.frontiersin.org/articles/10.3389/fnagi.2021.649902/full |
work_keys_str_mv |
AT nataliaeduardafurlan theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT gustavojoseluvizutto theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT pedrotadaohamamotofilho theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT silmeiagarciazanatibazan theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT gabrielpinheiromodolo theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT nataliacristinaferreira theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT luanaaparecidamiranda theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT julithomazdesouza theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT fernandacristinawinckler theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT edisoniglesiasdeoliveiravidal theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT carlosclaytonmacedodefreitas theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT luiscuadradomartin theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT rodrigobazan theimpactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT nataliaeduardafurlan impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT gustavojoseluvizutto impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT pedrotadaohamamotofilho impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT silmeiagarciazanatibazan impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT gabrielpinheiromodolo impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT nataliacristinaferreira impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT luanaaparecidamiranda impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT julithomazdesouza impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT fernandacristinawinckler impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT edisoniglesiasdeoliveiravidal impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT carlosclaytonmacedodefreitas impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT luiscuadradomartin impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy AT rodrigobazan impactofageonmortalityanddisabilityinpatientswithischemicstrokewhounderwentcerebralreperfusiontherapyabraziliancohortstudy |
_version_ |
1721317225958211584 |